학술논문
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors
Document Type
Article
Author
Robbrecht, D.; Grob, J.-J.; Bechter, O.; Simonelli, M.; Doger, B.; Borbath, I.; Butler, M.O.; Cheng, T.; Romano, P.M.; Pons-Tostivint, E.; Di Nicola, M.; Curigliano, G.; Ryu, M.-H.; Rodriguez-Vida, A.; Schadendorf, D.; Garralda, E.; Abbadessa, G.; Demers, B.; Amrate, A.; Wang, H.; Lee, J.S.; Pomponio, R.; Wang, R.
Source
In: Clinical and Translational Science . (Clinical and Translational Science, February 2024, 17(2))
Subject
Language
English
ISSN
17528062
17528054
17528054